Exenatide
A Pilot Study of Effects of Exenatide on Body Weight in Non-Diabetic, Obese Patients
AstraZeneca · Phase 2 · Completed · Enrollment 163
| Arm | Nausea | Vomiting | Diarrhea | Discontinuation | Deaths |
|---|---|---|---|---|---|
| Group A | 18 participants | 6 participants | 10 participants | n/r | n/r |
| Group B | 3 participants | 1 participants | 2 participants | n/r | n/r |
A count stays a count. This page does not turn a count into a percent.